Free Trial

Bio-Rad Laboratories (BIO) Competitors

$319.58
+4.41 (+1.40%)
(As of 07/26/2024 ET)

BIO vs. MTD, ILMN, WAT, TECH, CRL, BRKR, PACB, HBIO, TMO, and A

Should you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Illumina (ILMN), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry.

Bio-Rad Laboratories vs.

Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, community ranking, dividends, profitability, earnings, valuation and media sentiment.

Mettler-Toledo International has a net margin of 20.55% compared to Bio-Rad Laboratories' net margin of -12.37%. Bio-Rad Laboratories' return on equity of 3.59% beat Mettler-Toledo International's return on equity.

Company Net Margins Return on Equity Return on Assets
Bio-Rad Laboratories-12.37% 3.59% 2.55%
Mettler-Toledo International 20.55%-662.32%25.11%

Bio-Rad Laboratories has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500.

65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.1% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Mettler-Toledo International received 3 more outperform votes than Bio-Rad Laboratories when rated by MarketBeat users. However, 64.77% of users gave Bio-Rad Laboratories an outperform vote while only 57.17% of users gave Mettler-Toledo International an outperform vote.

CompanyUnderperformOutperform
Bio-Rad LaboratoriesOutperform Votes
364
64.77%
Underperform Votes
198
35.23%
Mettler-Toledo InternationalOutperform Votes
367
57.17%
Underperform Votes
275
42.83%

Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bio-Rad Laboratories$2.67B3.41-$637.32M-$10.36-30.85
Mettler-Toledo International$3.79B8.18$788.78M$35.6640.66

In the previous week, Mettler-Toledo International had 8 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 16 mentions for Mettler-Toledo International and 8 mentions for Bio-Rad Laboratories. Bio-Rad Laboratories' average media sentiment score of 0.74 beat Mettler-Toledo International's score of 0.18 indicating that Bio-Rad Laboratories is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bio-Rad Laboratories
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mettler-Toledo International
5 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Bio-Rad Laboratories currently has a consensus target price of $436.67, indicating a potential upside of 36.71%. Mettler-Toledo International has a consensus target price of $1,301.25, indicating a potential downside of 10.16%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities research analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bio-Rad Laboratories
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Mettler-Toledo International
2 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Mettler-Toledo International beats Bio-Rad Laboratories on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIO vs. The Competition

MetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE Exchange
Market Cap$9.11B$5.56B$5.27B$18.50B
Dividend YieldN/A0.42%2.79%3.51%
P/E Ratio-30.8519.24148.3724.32
Price / Sales3.414.872,041.4715.47
Price / Cash25.6042.1135.4219.61
Price / Book1.043.384.945.07
Net Income-$637.32M-$396,363.64$111.35M$976.63M
7 Day Performance7.67%7.68%2.70%1.50%
1 Month Performance14.89%9.49%11.35%6.13%
1 Year Performance-24.38%-31.15%9.87%7.83%

Bio-Rad Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MTD
Mettler-Toledo International
4.3291 of 5 stars
4.33 / 5 stars
$1,384.56
+1.7%
$1,301.25
-6.0%
+7.4%$29.08B$3.79B38.8317,300Upcoming Earnings
Short Interest ↓
Analyst Revision
News Coverage
ILMN
Illumina
4.8691 of 5 stars
4.87 / 5 stars
$116.29
+0.6%
$158.57
+36.4%
-38.1%$18.42B$4.50B-14.279,300Positive News
WAT
Waters
4.392 of 5 stars
4.39 / 5 stars
$305.50
+1.6%
$301.20
-1.4%
+8.3%$17.85B$2.96B29.987,900Upcoming Earnings
News Coverage
TECH
Bio-Techne
4.5868 of 5 stars
4.59 / 5 stars
$77.61
+1.4%
$81.00
+4.4%
-8.7%$12.06B$1.14B61.603,050Short Interest ↓
CRL
Charles River Laboratories International
4.5125 of 5 stars
4.51 / 5 stars
$222.41
+1.0%
$252.29
+13.4%
+5.2%$11.35B$4.13B26.1721,800News Coverage
Positive News
BRKR
Bruker
4.9756 of 5 stars
4.98 / 5 stars
$64.08
+3.1%
$81.78
+27.6%
-10.7%$9.03B$2.96B23.309,707Upcoming Earnings
Short Interest ↓
PACB
Pacific Biosciences of California
1.4578 of 5 stars
1.46 / 5 stars
$1.88
+1.6%
$6.38
+239.1%
-85.2%$503.86M$200.52M-1.65796Gap Up
HBIO
Harvard Bioscience
2.4452 of 5 stars
2.45 / 5 stars
$3.25
-1.5%
N/A-30.8%$143.32M$112.25M-16.25490Short Interest ↓
Gap Up
TMO
Thermo Fisher Scientific
4.8533 of 5 stars
4.85 / 5 stars
$574.79
+4.1%
$605.63
+5.4%
+4.1%$210.80B$42.86B36.87122,000Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
A
Agilent Technologies
4.5986 of 5 stars
4.60 / 5 stars
$134.22
+2.7%
$138.06
+2.9%
+6.0%$38.12B$6.83B31.7318,100Short Interest ↓
News Coverage

Related Companies and Tools

This page (NYSE:BIO) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners